News
Recalls, approvals and market changes that affect Canadians on GLP-1 medication. Each item is dated and cites the Health Canada record it comes from.
Health Canada Recall: One Lot of Apo-Semaglutide Pens May Show the Wrong Dose
A GLP-1 pen safety notice: one lot of generic semaglutide (Apotex) may display and deliver a lower dose than expected. Here is what to check and who to call.
Generic Semaglutide in Canada: Sandoz Approved, Not Yet Marketed
A third generic semaglutide has approval but no shelf presence. Here is where generic GLP-1 supply stands in Canada as of September 29.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.